ZEPOSIA Trademark

Trademark Overview

On Thursday, March 31, 2016, a trademark application was filed for ZEPOSIA with the United States Patent and Trademark Office. The USPTO has given the ZEPOSIA trademark a serial number of 86959853. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, July 19, 2023. This trademark is owned by Celgene Corporation. The ZEPOSIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
zeposia

General Information

Serial Number86959853
Word MarkZEPOSIA
Filing DateThursday, March 31, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, July 19, 2023
Registration Number5135866
Registration DateTuesday, February 7, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Translation of Words in MarkThe wording "ZEPOSIA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 5, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRECEPTOS LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressPrinceton, NJ 08543
Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Monday, May 9, 2016ASSIGNED TO LIE
Monday, April 4, 2016NEW APPLICATION ENTERED
Tuesday, April 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 21, 2016ASSIGNED TO EXAMINER
Friday, April 22, 2016NON-FINAL ACTION WRITTEN
Friday, April 22, 2016NON-FINAL ACTION E-MAILED
Friday, April 22, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 12, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 12, 2016PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, May 13, 2016NON-FINAL ACTION WRITTEN
Friday, May 13, 2016NON-FINAL ACTION E-MAILED
Friday, May 13, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 5, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 12, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 12, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 12, 2016NON-FINAL ACTION WRITTEN
Friday, August 12, 2016NON-FINAL ACTION E-MAILED
Wednesday, November 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, August 31, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 9, 2016ASSIGNED TO LIE
Thursday, September 22, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 22, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 14, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 22, 2016PUBLISHED FOR OPPOSITION
Tuesday, November 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, February 7, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 24, 2023TEAS SECTION 8 & 15 RECEIVED
Wednesday, July 19, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 19, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, September 19, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 19, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 19, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 19, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 13, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 19, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

zeposia pharmaceutical disease preparations namely diseases skin cytokine musculoskeletal inhibitory immune